4.5 Article

Cytosolic d-type CpG-oligonucleotides induce a type I interferon response by activating the cGAS-STING signaling pathway

Journal

EUROPEAN JOURNAL OF IMMUNOLOGY
Volume 51, Issue 7, Pages 1686-1697

Publisher

WILEY
DOI: 10.1002/eji.202048810

Keywords

cGAMP; cGAS; CpG‐ oligonucleotide; immunotherapy; innate immunity; interferons; pattern recognition receptors; STING; toll‐ like receptor 9; type I interferon

Categories

Funding

  1. Department of Anesthesiology and Critical Care Medicine, University Medical Center, University of Bonn, Germany

Ask authors/readers for more resources

cGAS plays a critical role in detecting cytosolic DNA and initiating a type I interferon response through STING and IRF3. Unlike TLR9, cGAS binding to dsDNA is length-dependent, not sequence-dependent.
Cytosolic DNA receptor cyclic GMP-AMP (cGAMP) synthase (cGAS) has been shown to be critically involved in the detection of cytosolic, self- and non-self-DNA, initiating a type I IFN response through the adaptor protein Stimulator of Interferon Genes (STING) and interferon regulatory factor 3 (IRF3). Current studies propose that canonical binding of dsDNA by cGAS depends on DNA length, but not on base sequence. In contrast, activation of TLR9 is sequence dependent. It requires unmethylated CpG dinucleotides in microbial DNA, which is mimicked by synthetic oligodeoxynucleotides (ODN). Here, we provide evidence that d-type ODN (D-ODN), but not K-type ODN (K-ODN), bind to human cGAS and activate downstream signaling. Transfection of D-ODN into a TLR9-deficient, human monocytic cell line (THP-1) induced phosphorylation of IRF3 and secretion of IFN. This response was absent in cells with CRISPR/Cas9-mediated cGAS- or STING-deficiency. Utilizing a protein pulldown approach, we further demonstrate direct binding of D-ODN to cGAS. Induction of a type I IFN response by D-ODN was confirmed in human primary monocytes and monocyte-derived macrophages. These results are relevant to our understanding of self-nonself-discrimination by cGAS and to the pharmacologic effects of ODN, which currently are investigated in clinical studies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available